Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV Vaccine

NCT01949857 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT01949857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV Vaccine
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2013
Completion date
June 30, 2016
Enrollment
35,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a